
May 29, 2025, 22:38
Prerana Jha on ctDNA Molecular Profiling in Indian Lung Cancer Patients Study
Prerana Jha, Director – Lab Operations at the Bencos Research Solutions Pvt Ltd, shared a post on LinkedIn about her recent study:
“Thrilled to share our Landmark publication-the first and largest clinical dataset on “ctDNA Molecular Profiling in Indian Lung Cancer Patients”!
This study reveals critical molecular alterations and demonstrates high concordance with tissue biopsy as a transformative non-invasive tool in precision oncology.
I am proud to this collaborative effort and heartfelt thanks to Karkinos Healthcare where this study was conducted.
Grateful to Dr Prashant Kumar for his unwavering support and guidance, and to Dr Kumar Prabash, Dr Vanita Noronha, Dr. Govind Babu, Dr. Amit Rauthan and Dr. Sewanti Limaye, MBBS, MD, MS for their pivotal role in making this possible.
Also thanks to the entire team, Dr. Asim Joshi, Rohit Mishra and Dr. Neha Sharma who contributed to this significant milestone.
This study is a significant step forward for personalized cancer care in India and beyond!”
Title: Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience
Journal: The Journal of Liquid Biopsy
Authors: Prerana Jha, Rohit Mishra, Asim Joshi, Neha Sharma, Minit Shah, Govind Babu, Amit Rauthan, Sewanti Limaye, Nandini Menon, Venkataramanan Ramachandran, Vanita Noronha, Prashant Kumar, Kumar Prabhash
Read more on ctDNA Analysis in lung cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 22:38
May 29, 2025, 22:26